ACON News and Press, Aclarion Inc. From 01/06/26

Northwestern and Scripps Health join two previously announced sites in achieving this critical patient enrollment milestone Seven leading U.S. spine centers have now completed the regulatory and operational requirements to screen and enroll patients in CLARITY First readout on interim...

A look at the top 10 most actives in the United States Profusa Inc. (PFSA) rose 85.4% to $0.1266 on volume of 803,202,968 shares Oriental Culture Holding LTD (OCG) rose 17.6% to $0.0977 on volume of 337,220,598 shares Autonomix Medical Inc. (AMIX) rose 8.1% to $0.5786 on volume of 131,465,4...

Featured article strengthens growing body of clinical evidence for Nociscan by highlighting a successful case study Special Pain issue features breakthrough innovations shaping the future of spine care IJSS publishes over 150 articles annually representing 40+ nations ...

Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companies Strong track record of launching breakthrough technologies across spine, neurosurgery and pain management Strengthens ...

Marks Aclarion’s first commercial sales hire with seasoned HealthTech leader and proven track record of advancing musculoskeletal imaging and spinal surgery Experiencing strong commercial traction in UK as first market worldwide with private insurers covering Nociscan ...

Company previously announced it was selected as a finalist from more than 1,800 submissions Award win underscores growing impact of Aclarion’s breakthrough Nociscan solution for chronic low back pain BROOMFIELD, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc ....

2025-10-15 11:31:04 ET AI-driven Nociscan platform posts 89% scan growth year-over-year; pivotal CLARITY trial advancing toward early 2026 data readout. A commercial-stage healthcare technology company using AI-powered biomarkers to pinpoint the source of chronic low back pain Aclar...

Debt-free balance sheet with $13.3 million in cash as of today ($15.11 per share fully diluted) providing strategic flexibility for continued commercial growth Nociscan scan volumes increase +89% year-over-year with third consecutive quarter of record utilization across U.S., U.K., and E....

2025-10-13 10:10:27 ET DENVER, Colo., Oct 13, 2025 ( 247marketnews.com )- Kraig Biocraft Laboratories (OTCQB:KBLB) surged into the spotlight this morning after announcing a major breakthrough in its recombinant spider silk production. The company unveiled BAM-1 Alpha , a new sil...

Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer Pain Session Co-Moderator Doug Beall, M.D. underscored that disc chemistry is the critical biomarker for diagnosing the leading cause of chronic low bac...